Abstract

BackgroundWhile 5-10% of axial spondyloarthritis (axSpA) patients have diagnosed inflammatory bowel disease (IBD), 50-60% display microscopic gut inflammation upon examination of mucosal biopsies. Gut inflammation, as measured by faecal calprotectin...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call